View DividendMEDYSSEYLtd マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報 最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間データなし経営陣の近況MEDYSSEY Co.,Ltd, Annual General Meeting, Mar 23, 2021Feb 25すべての更新を表示Recent updatesMEDYSSEY Co.,Ltd, Annual General Meeting, Mar 23, 2021Feb 25New 90-day low: ₩7,650 Feb 22New 90-day low: ₩8,070 Feb 04New 90-day high: ₩9,930 Dec 22Dongwha Pharm.Co.,Ltd (KOSE:A000020) completed the acquisition of 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim.Sep 26Dongwha Pharm.Co.,Ltd (KOSE:A000020) agreed to acquire 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion.Sep 25New 90-day high - ₩9,070 Sep 08New 90-day high - ₩6,760 Jul 24CEO（最高経営責任者MEDYSSEYLtd CEOがいない、あるいは彼らに関するデータがない。View Ownership
Dongwha Pharm.Co.,Ltd (KOSE:A000020) completed the acquisition of 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim.Sep 26
Dongwha Pharm.Co.,Ltd (KOSE:A000020) agreed to acquire 53.3% stake in MEDYSSEY Co.,Ltd (XKON:A200580) from Jongwook Jang, Min-kyung Jang, Ho-jeong Kim, Ji-won Jang and Seon-ok Kim for KRW 19.6 billion.Sep 25